Tesamorelin

Tesamorelin is a research-grade synthetic analog of growth hormone-releasing hormone (GHRH), designed for experimental studies on visceral fat reduction, metabolic health, and pituitary function in aging and HIV-associated lipodystrophy models. This tesamorelin 44-amino acid peptide stimulates pulsatile GH secretion to explore IGF-1 elevation, lipolysis enhancement, and body composition optimization without direct GH administration.

Core Benefits

• Targets abdominal adipose tissue reduction via increased lipolytic activity and GH/IGF-1 axis activation, with clinical research showing significant decreases in visceral fat mass and waist circumference.

• Improves lipid profiles, insulin sensitivity, and triglyceride levels, supporting investigations into metabolic syndrome and dyslipidemia in endocrine models.

• Enhances lean body mass preservation and potentially cognitive function through GH-mediated pathways, as evidenced in studies on age-related sarcopenia and hepatic fat accumulation.

For research purposes only. Not intended for human consumption.